Hassan, M.S.; Johnson, C.; Ponna, S.; Scofield, D.; Awasthi, N.; von Holzen, U.
Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma. Cancers 2024, 16, 3175.
https://doi.org/10.3390/cancers16183175
AMA Style
Hassan MS, Johnson C, Ponna S, Scofield D, Awasthi N, von Holzen U.
Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma. Cancers. 2024; 16(18):3175.
https://doi.org/10.3390/cancers16183175
Chicago/Turabian Style
Hassan, Md Sazzad, Chloe Johnson, Saisantosh Ponna, Dimitri Scofield, Niranjan Awasthi, and Urs von Holzen.
2024. "Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma" Cancers 16, no. 18: 3175.
https://doi.org/10.3390/cancers16183175
APA Style
Hassan, M. S., Johnson, C., Ponna, S., Scofield, D., Awasthi, N., & von Holzen, U.
(2024). Inhibition of Insulin-like Growth Factor 1 Receptor/Insulin Receptor Signaling by Small-Molecule Inhibitor BMS-754807 Leads to Improved Survival in Experimental Esophageal Adenocarcinoma. Cancers, 16(18), 3175.
https://doi.org/10.3390/cancers16183175